American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Banco Bradesco
BBD
$34.3B
| $3.74M | ﹤0.01% |
1,147,881
+295,701
| +35% | +$1.14M |
|
1202
Darling Ingredients
DAR
$10.4B
| $3.74M | ﹤0.01% |
62,488
+14,261
| +30% | +$1.08M |
|
1203
Campbell Soup
CPB
$6.94B
| $3.73M | ﹤0.01% |
77,706
-1,596
| -2% | -$75.2K |
|
1204
National Bank Holdings
NBHC
$1.94B
| $3.73M | ﹤0.01% |
97,571
+18,768
| +24% | +$730K |
|
1205
Insteel Industries
IIIN
$634M
| $3.73M | ﹤0.01% |
110,869
+28,575
| +35% | +$1.14M |
|
1206
FB Financial Corp
FBK
$3.1B
| $3.72M | ﹤0.01% |
94,938
+51,983
| +121% | +$2.09M |
|
1207
Relay Therapeutics
RLAY
$4.37B
| $3.7M | ﹤0.01% |
221,084
+16,201
| +8% | +$347K |
|
1208
Amerant Bancorp
AMTB
$1.14B
| $3.7M | ﹤0.01% |
131,663
+39,016
| +42% | +$1.11M |
|
1209
Coeur Mining
CDE
$19B
| $3.69M | ﹤0.01% |
1,214,439
+379,608
| +45% | +$1.49M |
|
1210
Canadian National Railway
CNI
$77.2B
| $3.68M | ﹤0.01% |
32,739
-50,896
| -61% | -$5.95M |
|
1211
Carlyle Group
CG
$18.3B
| $3.68M | ﹤0.01% |
116,272
+25,498
| +28% | +$977K |
|
1212
HF Sinclair
DINO
$16.3B
| $3.68M | ﹤0.01% |
81,517
-418,427
| -84% | -$18.7M |
|
1213
Primerica
PRI
$9.62B
| $3.68M | ﹤0.01% |
30,755
+17,048
| +124% | +$2.14M |
|
1214
Telkom Indonesia
TLK
$14.5B
| $3.67M | ﹤0.01% |
135,579
+26,467
| +24% | +$791K |
|
1215
Fidelity National Financial
FNF
$13.1B
| $3.65M | ﹤0.01% |
102,710
-21,058
| -17% | -$823K |
|
|
AAN
1216
DELISTED
The Aaron's Company Inc
AAN
| $3.63M | ﹤0.01% |
249,143
+59,286
| +31% | +$1.13M |
|
|
ABB
1217
DELISTED
ABB Ltd
ABB
| $3.62M | ﹤0.01% |
135,486
-13,270
| -9% | -$394K |
|
1218
Paychex
PAYX
$44.6B
| $3.61M | ﹤0.01% |
31,733
+8,981
| +39% | +$1.13M |
|
1219
Scholastic
SCHL
$784M
| $3.61M | ﹤0.01% |
100,364
+58,601
| +140% | +$2.16M |
|
1220
Arcus Biosciences
RCUS
$3.67B
| $3.61M | ﹤0.01% |
142,367
+24,652
| +21% | +$604K |
|
|
COWN
1221
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $3.6M | ﹤0.01% |
152,101
+34,911
| +30% | +$848K |
|
1222
Titan Machinery
TITN
$420M
| $3.6M | ﹤0.01% |
160,637
+34,213
| +27% | +$853K |
|
1223
Zumiez
ZUMZ
$319M
| $3.6M | ﹤0.01% |
138,399
+12,769
| +10% | +$430K |
|
1224
Upbound Group
UPBD
$1.15B
| $3.6M | ﹤0.01% |
184,860
+163,304
| +758% | +$4.06M |
|
1225
ADC Therapeutics
ADCT
$134M
| $3.59M | ﹤0.01% |
451,827
+30,530
| +7% | +$289K |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.